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Abstract
The molecular chaperone Hsp90 has been found to be essential for viability in all tested eukaryotes, from the budding yeast
to Drosophila. In mammals, two genes encode the two highly similar and functionally largely redundant isoforms Hsp90a
and Hsp90b. Although they are co-expressed in most if not all cells, their relative levels vary between tissues and during
development. Since mouse embryos lacking Hsp90b die at implantation, and despite the fact that Hsp90 inhibitors being
tested as anti-cancer agents are relatively well tolerated, the organismic functions of Hsp90 in mammals remain largely
unknown. We have generated mouse lines carrying gene trap insertions in the Hsp90a gene to investigate the global
functions of this isoform. Surprisingly, mice without Hsp90a are apparently normal, with one major exception. Mutant male
mice, whose Hsp90b levels are unchanged, are sterile because of a complete failure to produce sperm. While the
development of the male reproductive system appears to be normal, spermatogenesis arrests specifically at the pachytene
stage of meiosis I. Over time, the number of spermatocytes and the levels of the meiotic regulators and Hsp90 interactors
Hsp70-2, NASP and Cdc2 are reduced. We speculate that Hsp90a may be required to maintain and to activate these
regulators and/or to disassemble the synaptonemal complex that holds homologous chromosomes together. The link
between fertility and Hsp90 is further supported by our finding that an Hsp90 inhibitor that can cross the blood-testis
barrier can partially phenocopy the genetic defects.
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Introduction
Hsp90 is an ubiquitous, highly conserved protein, comprising up
to 2% of total cell proteins even under non-stressed conditions. It
facilitates the folding and activity of a large number and variety of
client proteins. The list of Hsp90 interacting proteins has already
grown to almost 300 proteins and it keeps growing. The activity of
Hsp90 is modulated by the interaction with a variety of co-
chaperones, which can act as regulators of the ATPase activity,
influence the choiceofclients, target client proteins for degradation,
recruit other co-chaperones, or affect the cellular localization of the
clients [1–4] (for a comprehensive and updated summary of Hsp90
facts, see http://www.picard.ch/downloads/Hsp90facts.pdf]). In
humans and mice, there are two cytosolic Hsp90 isoforms, encoded
by two separate genes, Hsp90a (gene Hsp90aa1) and Hsp90b (gene
Hsp90ab1). With 85.8% sequence identity and 93.4% similarity, the
two isoforms are highly homologous. Whereas Hsp90b is more or
less constitutively and ubiquitously expressed, the expression of
Hsp90a is heat-inducible and more tissue-specific [5].
So far, there is only limited evidence for isoform-specific
functions. Provided the two isoforms are expressed at all, they are
thought to be largely redundant. The known exceptions include
the specific participation of Hsp90a in antigen processing [6] and
in blocking caspase-2 activation [7]. It has also been demonstrated
that Hsp90a can be secreted to promote the maturation of matrix
metalloprotease 2 and cell invasiveness in metastasis [8], and cell
migration in wound healing [9]. Recently, it was suggested that
Hsp90a might play a role in female meiosis in the mouse, notably
in the G2/M transition [10]. A role for Hsp90 in spermatogenesis
had first been described in Drosophila melanogaster, where males with
certain transheterozygous combinations of mutant hsp90 alleles are
sterile and display a disrupted meiosis, possibly due to a defect in
microtubule dynamics [11]. A study on testis in newt showed a role
for Hsp90b in prolactin-induced apoptosis of spermatogonia [12].
The in vivo role of the Hsp90 machinery has been mainly
investigated by genetic studies in yeast and pharmacologically with
mammalian tissue culture cells. In contrast, the genetic analysis of
the Hsp90 chaperone machine in the mouse is still in its infancy.
PLoS ONE | www.plosone.org 1 December 2010 | Volume 5 | Issue 12 | e15770Although an Hsp90b gene disruption was found to be early
embryonic lethal ten years ago [13], this finding was not further
investigated. Mutational analyses of some of the co-chaperones
such as FKBP51, FKBP52 and p23 have highlighted the
complexity of the Hsp90 machinery and the fact that interesting
insights can be gained from genetically ablating components of this
important housekeeping chaperone machine [14–16]. The aim of
this study was to investigate genetically the in vivo role of Hsp90a,
the other core component of this molecular machine, in the
mouse.
Results
Generation of Hsp90a gene disruption mutants in the
mouse
In order to assess the role of Hsp90a in vivo, a mutant mouse line
was established from an embryonal stem cell clone carrying a gene
trap insertion in the last intron of the Hsp90aa1 gene (Fig. 1A).
This particular insertion of a gene trap vector into intron 10 could
potentially encode an in-frame fusion protein consisting of a
truncated Hsp90a lacking the C-terminal 36 amino acids and a b-
galactosidase-neomycine resistance gene (bGeo). The very C-
terminal domain of Hsp90a comprises the conserved sequence
motif MEEVD, which is essential for the interaction with the
tetratricopeptide repeats present in some Hsp90 co-chaperones.
This is notably the case for the large immunophilins Cyp-40,
FKBP51 and FKBP52, the serine–threonine protein phosphatase
5 and CHIP [17,18]. A more extensive portion of the C-terminal
domain is required for dimerization and for viability in the
budding yeast [19]. Whereas a truncation mutant of the C-
terminal 24 amino acids of yeast Hsp90 is sufficient for viability, a
truncation of 57 amino acids is not [20]. Moreover, while a wild-
type version of mammalian Hsp90a complements the budding
yeast [19,21], a Hsp90aD35 mutant, which can be considered
intermediate between the two afore-mentioned yeast mutants, is
severely defective for complementation (Morag McLean and DP,
unpublished results). Therefore, it is likely that such a truncation,
even if it were expressed at normal levels, would be largely
dysfunctional.
An immunoblotting experiment with specific antibodies showed
that Hsp90a is expressed in a pronounced tissue-specific pattern
with high levels in testis and almost none in heart and skeletal
muscle (Fig. 1B). By comparison, Hsp90b is expressed much more
evenly across the same panel of tissues. To determine if any
residual or fused Hsp90a protein persists in gene disruption
mutants, we analysed the same tissues from homozygous mutant
mice. Even though the polyconal antiserum against Hsp90a that
was used would have been able to recognize the slightly truncated
form, no wild-type Hsp90a or Hsp90aD36-bGeo could be
detected in any of the analysed tissues (Fig. 1B, and data not
Figure 1. Functional disruption of the Hsp90a gene in the mouse. (A) Schematic representation of the disruption of the mouse Hsp90aa1
gene by insertion of a gene trap (GT) in intron 10 (in mutant mouse line 1). Open and black boxes indicate non-coding and coding exons,
respectively. The gene trap consists of a splice acceptor (SA), a b-galactosidase-neomycin resistance fusion (bGeo) and an SV40 polyadenylation site.
(B) Immunoblots showing the expression of Hsp90a and Hsp90b in a panel of tissues in wild-type (WT) and mutant (gt/gt) mice (of 136 days
postnatal). The Ponceau S staining of the immunoblot filter gives an indication of protein loading.
doi:10.1371/journal.pone.0015770.g001
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almost all Hsp90a protein. It is noteworthy that the absence of
Hsp90a is not compensated by an increase in Hsp90b. In view
of subsequently confirming the key results obtained with this
particular gene disruption line, we also generated and investigated
another Hsp90aa1 gene trap insertion mutant (gene trap mutant 2),
in which the gene trap insertion occurred before the first coding
exon. We expected this insertion to result in a complete disruption
of the Hsp90a transcript and of Hsp90a protein expression (Fig.
S1; see below). Since the testicular phenotype obtained for both
lines appeared to be identical (Fig. S1), we concluded that both
lines correspond to functional gene disruptions of the Hsp90aa1
gene, and continued our analysis primarily with the gene trap
mutant 1.
Hsp90a is required for spermatogenesis
Male and female mice homozygous for the gene trap mutation
1, from here on referred to as hsp90a
gt/gt, were viable, grew to
adulthood normally and appeared to have normal sexual beha-
viour when compared to control littermates. Female hsp90a
gt/gt
mice were fertile and displayed no obvious ovarian abnormalities
(data not shown). In hsp90a
gt/gt males, testicular descent occurred
and internal reproductive organs such as seminal vesicles and
prostate were normally masculinized (Fig. 2A, and data not
shown). Male hsp90a
gt/gt mice exhibited normal androgen-
dependent behaviour including mounting and copulatory activity
(data not shown). However, they appeared to be sterile as repeated
breeding between hsp90a
gt/gt males and wild-type females failed to
produce any offspring. When the testicular weight of hsp90a
gt/gt
males from postnatal day 14 (P14) until P44 was analysed, it
showed a progressive reduction in size, reaching 66% at postnatal
day P44 compared to that of wild-type littermates (Fig. 2B). A
sperm count analysis revealed that no spermatozoa were present in
the caudal epididymis of one year old hsp90a
gt/gt males (Fig. 2C).
The same was true for 9 months old males whereas normal sperm
counts were found in hsp90a
+/gt heterozygous littermates (data not
shown). Thus, except for azoospermia (‘‘absence of sperm’’), it
appeared that Hsp90a function is dispensable for development
and basic physiology.
Hsp90a is important for meiotic progression in testis
To determine where and when the defect in testis development
begins in hsp90a
gt/gt males, we compared the development of
mutant and control testes from P0 to P44, when the first
spermatogenic wave is completed, by histology (Fig. 3A). Prior
to P15, mutant and control testes appeared morphologically
indistinguishable, indicating that immature Sertoli cells, spermato-
gonia and early meiotic germ cells developed normally (data not
shown). The first abnormalities began to appear at P15 when
hsp90a
gt/gt mutant testes ceased to grow (Fig. 3A). The detailed
histological examination of P21, P44 and P111 hsp90a
gt/gt mutant
testes revealed that meiosis is impaired. It does not progress further
than spermatocyte differentiation as no post-meiotic spermatids
were observed, and mature spermatozoa in the seminiferous
tubules and epididymal ducts were completely missing. Already at
P15, when germ cells reach the pachytene stage, cells with typical
apoptotic morphology were present in a few tubules. Later at P21
and P44, the phenotype became more severe with a variety of
defects ranging from the presence of vacuoles in some mutant
tubules lacking spermatocytes to a Sertoli-cell-only (SCO)
phenotype at P111 in some cases (Fig. 3A). A lot of pycnotic
and multinuclear cells, and primary spermatocytes could be
observed suggesting an arrest at the pachytene stage of meiosis I.
To confirm the absence of post-meiotic cells, we analysed
testicular cell populations at P44 by flow cytometry. The
experiment confirmed the absence of 1n cells in the testis of
hsp90a
gt/gt mice, normally present at this stage of spermatogenesis
as shown for wild-type littermates (Fig. 3B). Moreover, the flow
cytometric analysis revealed an increased 4n cell population
suggesting a meiotic arrest at prophase I.
Since hsp90a
gt/gt seminiferous epithelium lacked post-meiotic
cells, we used a TUNEL assay to investigate whether the missing
cells are eliminated by apoptosis. hsp90a
gt/gtmurine testes at P21
Figure 2. Absence of Hsp90a leads to atrophic testis and
azoospermia. (A) Morphology of seminal vesicles and testis of wild-
type (WT) and hsp90a
gt/gt mutant (gt/gt) mice at P44. (B) Time course
analysis of testis weight in WT and mutant (gt/gt) animals. n$4. (C) No
mature sperm cells could be detected in the epididymis of one year old
hsp90a
gt/gt animals.
doi:10.1371/journal.pone.0015770.g002
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controls (Fig. 3C). Thus, the loss of Hsp90a function results in
male-specific infertility due to an incapacity of germ cells to
complete meiosis leading to a spermatogenesis arrest, and
ultimately cell death of meiotic spermatocytes.
The testicular phenotype is restricted to germ cells
To investigate which testicular cell type might be affected in the
resulting phenotype, we measured the expression of a set of
markers at P44 to assess the relative proportions of Leydig cells,
Sertoli cells, and germ cells. The quantitative PCR data showed
that there are no major differences in expression of specific
markers for the somatic Leydig (Insl3 and Star) and Sertoli (Amh)
cells between hsp90a mutant and wild-type testes while the germ
cell marker Pou5f1 (Oct4) is practically absent in the mutant
(Fig. 4A). Sertoli cell dysfunction can be associated with infertility.
However, as pointed out above, hsp90a
gt/gt mutant mice had
seminal vesicles of normal size (Fig. 2A), and the maturation of
Sertoli cells appeared normal, as reflected by the formation of a
lumen indicative of a normal secretory activity. Nevertheless, we
further examined the presence of GATA4 by immunohistochem-
istry (Fig. S2A). In mature adult testes, GATA4 is primarily
present in Sertoli cells. The results showed a typical Sertoli cell
staining as well as the presence of SCO tubules with an apparently
normal quantity of Sertoli cells in mutant testes. Similarly the
expression of several other classical markers of Sertoli cell function
such as Inha (a-inhibin), Gata1, kitl (Steel), and Trf (transferrin),
was even higher in mutant testes at the mRNA level (Fig. S2B).
Thus, the markers suggest that Sertoli cells are present and
normally differentiated in mutant animals. Taken together, these
observations suggest that the testicular defects observed in
hsp90a
gt/gt mutants are unlikely to result from a dysfunction of
Sertoli cells or a defect in responding to androgens.
Pachytene arrest in hsp90a mutant germ cells
To determine more precisely at which meiotic stage spermato-
genesis gets disrupted in hsp90a
gt/gt seminiferous epithelium, we
examined the expression of spermatogenic markers at P44.
Haploid-specific transcripts were absent, confirming that germ
cell differentiation beyond the meiotic division was halted (Fig. 4B).
Similarly, Ccna1 (Cyclin A1), Sprm1 and Cdc25c transcripts,
which should appear in late pachytene spermatocytes, were
drastically reduced in hsp90a
gt/gt testes (Fig. 4C). The level of
expression of Hoxa4, which is expressed from mid-pachytene
spermatocytes to when round spermatids are formed [22], was also
significantly reduced (Fig. 4C). Overall, these findings demonstrate
a germ-cell specific blockade in meiotic progression at the mid to
late pachytene transition.
Meiosis and progression through it are tightly controlled
processes. It is during the meiotic prophase that homologous
chromosomes recombine. Meiotic recombination involves the
programmed induction of DNA double-stranded breaks (DSBs) at
the beginning of prophase. These DSBs are then repaired by
interaction with the homologues during the zygotene and
pachytene stages. In coordination with DSB repair, homologous
chromosome axes become tightly associated through a proteina-
ceous structure called the synaptonemal complex (SC). During
pachytene, homologs are fully synapsed along their length, DSB
Figure 3. Meiotic arrest and apoptosis in hsp90a
gt/gt mutant testis. (A) Histological sections of testes of of wild-type (WT) and mutant (gt/gt)
mice at 15, 21, 44 and 111 days after birth. In the righthand panels, arrows point out apoptotic nuclei and the asterisk in the P111 section indicates
degenerating tubules. (B) Flow cytometric analysis of the DNA contents of the whole testis cell population at P44. (C) TUNEL analysis of sections of
P21 testes.
doi:10.1371/journal.pone.0015770.g003
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to crossing-overs [23]. When meiosis progresses into diplotene, the
SC disassembles and homologous chromosomes remain connected
at the sites of crossing-over. Defects in recombination or synapsis
in spermatocytes lead to a meiotic arrest in response to the
pachytene checkpoint [24]. Therefore, to investigate the meiotic
defect in more detail, we prepared surface spread chromosomes
from hsp90a
gt/gt spermatocytes. Staining for the lateral and central
SC components Sycp3 and Sycp1, respectively, revealed a normal
chromosome integrity and synapsis of homologues in mutant
spermatocytes in prophase I (Fig. 5). Likewise, the formation of
DSBs as revealed by cH2AX staining as well as ongoing repair
highlighted by DMC1 staining were normal and indistinguishable
from wild-type (Fig. S3). There was also no change in the
successful formation of crossing-overs and hence successful
homologous recombination as shown by MLH1 staining. Strik-
ingly, we did not find any chromosome spreads indicative of stages
beyond pachytene in hsp90a
gt/gt samples (Fig. 5 and S3). These
results demonstrate that Hsp90a is neither required for meiotic
recombination nor SC formation. In contrast, Hsp90a seems to be
indispensable for SC disassembly and/or progression through late
pachytene or the pachytene checkpoint.
The presence of Hsp90a is crucial during the first wave of
spermatogenesis
Unlike the permanent disruption of Hsp90a expression in gene
trap mutant line 1 (data not shown), we were surprised to find a
somewhat different situation with line 2. A detailed analysis of the
expression of Hsp90a in the testes of gene trap mutant line 2 over
time revealed that the expression of Hsp90a, albeit initially
strongly reduced, resumes around P45 (Fig. S1B). The Hsp90a
protein levels progressively increase until, at 8 months, they reach
the levels found in wild-type animals in all tissues analysed (Fig.
S1B and S1C). Despite the fact that the Hsp90a expression was
not permanently disrupted in this mutant, the adult males
remained infertile (data not shown). These data support a crucial
role of Hsp90a in the mouse before puberty when the first wave of
spermatogenesis takes place.
Exploring the mechanism
To explore the molecular mechanism responsible for the hsp90a
mutant phenotype, we wanted to look at changes of potential
Hsp90 target proteins that are known to play a role in
spermatogenesis, particularly relating to the pachytene arrest.
One obvious difficulty of this type of analysis is that the cell
populations are altered in the testes of hsp90a
gt/gt mutant animals
with ultimately a very severe depletion of germ cells relative to
somatic cells. Although this must be taken into account in
interpreting observed changes, it should be emphasized that the
depletion is progressive and that only the late stages of
spermatogenesis are missing early on, for example at P21. With
this caveat in mind, we compared the levels of various proteins in
protein extracts from the testes of hsp90a
gt/gt (mutant line 1) and
wild-type animals from the age of P12 (onset of pachytene) to P44
(completion of the first spermatogenic wave) by immunoblotting.
Hsp70-2 (= Hspa2) is a testis-specific isoform of the molecular
chaperone Hsp70, which is associated with SCs [25]. In Hsp70-2
knock-out mice, the transition of spermatocytes from prophase I to
metaphase I fails to occur as well [26]. Moreover, it had been
shown that an unspecified Hsp70 isoform coprecipitates with both
Hsp90 isoforms in murine testis extracts [27]. We therefore
investigated the levels of Hsp70-2 in testicular extracts from
hsp90a
gt/gt and wild-type mice. Already somewhat reduced at P16,
Hsp70-2 protein levels were further diminished to only 30% at
P44 in mutants relative to wild-type mice (Fig. 6).
Cyclin B and Cdc2 (= Cdk1) form the maturation/M-phase
promoting factor (MPF), which is essential for meiotic progression
[28]. The spermatogenesis arrest in cyclin A1 or Hsp70-2 knock-
out mice appears to be the result of a failure to activate Cdc2 by
dephosphorylation [29,30]. Since both cyclin B [31] and Cdc2
[32] are known Hsp90 clients, we examined the protein levels of
cyclin B and Cdc2, and the phosphorylation status of Cdc2. In
Figure 4. Quantitative RT-PCR analysis of specific markers
indicates pachytene arrest in the germ cells of hsp90a
gt/gt
mutant mouse testis. RNA samples are from P44 mice. (A) Markers of
testis compartments. Insl3 and Star, Amh, and Pou5f1 are for Leydig,
Sertoli, and germ cells, respectively. (B) Complete absence of post-
meiotic markers. (C) Markers of advanced stages of meiosis.
doi:10.1371/journal.pone.0015770.g004
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gt/gt mouse testes, the levels of total Cdc2
were already decreased at P21. At P44, an increase of cyclin B
with a concomitant reduction of Cdc2 was observed compared to
the wild-type controls (Fig. 6, panels 2 and 3). The levels of the
inactive Tyr15-phosphorylated form of Cdc2 in hsp90a
gt/gt as
compared to the wild-type animals at the latest stages of the
spermatogenic progression were lower, but not as pronounced as
for the de-phosphorylated form (Fig. 6, panel 4). This indicates an
even more pronounced relative reduction of the active (dephos-
phorylated) form, potentially contributing to the pachytene arrest.
Nuclear autoantigenic sperm protein (NASP) binds and
transports the testis-specific linker histone H1t to the nucleus.
Although the H1t knock-out in the mouse did not affect
spermatogenesis [33], NASP was demonstrated to be involved
with cell cycle progression in tissue culture cells [34], probably
through an interaction with the Cdc2/cyclin B and Hsp70-2
Figure 5. Chromosome spreads of meiotic cells. Absence of the diplotene stage in hsp90a
gt/gt mutant germ cells of animals at P28. Staining of
Sycp1 (in green) and Sycp3 (in red) reveals normal chromosome synapsis in hsp90a
gt/gt (gt/gt) mutant germ cells until pachytene. There is a complete
absence of diplotene spreads in hsp90a
gt/gt mutants. Blue, DAPI staining of DNA.
doi:10.1371/journal.pone.0015770.g005
Figure 6. Immunoblot analysis of a panel of Hsp90- and Hsp70-related proteins. The results shown are from a representative analysis of
testis extracts from wild-type and mutant animals from P12 until completion of the first wave of spermatogenesis at P44. GAPDH serves as loading
control. Note that the order of the sample pairs is reversed for the P16 and P18 samples at the center of the blots (area highlighted by hairlines).
doi:10.1371/journal.pone.0015770.g006
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associated with Hsp90a and to stimulate its ATPase activity [36].
The immunoblots of the testes of hsp90a
gt/gt and wild-type animals
showed a dramatic reduction in NASP levels in mutant animals,
beginning at age P18 (Fig. 6, panel 5). These findings are
compatible with an involvement of Hsp90a in NASP activation
and/or stabilisation.
An Hsp90 inhibitor disrupts testicular development
Hsp90 is a promising drug target for anticancer therapies and
several drug candidates are already in clinical trials [37]. In light of
our genetic data, we decided to determine whether an Hsp90
inhibitor could induce a pharmacological phenocopy. Although
geldanamycin and its derivatives have been extensively character-
ized and widely used, including in clinical trials [37], these do
unfortunately not pass the blood-brain and blood-testis barriers
[38]. Therefore, we resorted to pochoxime A, a new radicicol
derivative with a promising cellular efficacy and lower toxicity
compared to geldanamycin and radicicol [39–41]. Note that
pochoxime, like all other known Hsp90 inhibitors, does not
discriminate between the Hsp90a and Hsp90b isoforms. In a pilot
experiment, a single intraperitoneal injection of a high dose of
pochoxime (100 mg/kg of body weight) into an adult male mouse
(4 months old) did not result in any obvious abnormalities three
weeks later (n=2, data not shown). We then decided to assess the
effects of the continuous presence of the inhibitor in pubertal
males throughout the first wave of spermatogenesis from P12 to
P25. Whereas the animals did not present any internal organ
abnormalities, the overall weight of the testis of the treated group
was around 25% smaller than that of the control group, and some
of the testes of the treated animals even became atrophic (Fig. 7).
In the latter, histological examination revealed a complete
disruption of the organization of the seminiferous epithelium,
apparently different from the specific pachytene arrest observed in
Hsp90a mutant animals (data not shown). Although the drug-
induced phenotype is not identical to that of the genetic disruption
of Hsp90a, it is testis-specific. The differences between the genetic
and drug-induced phenotypes might stem from the fact that in the
mutated animals, Hsp90a is absent during the complete process of
spermatogenesis, while pochoxime A was injected only during a
short interval around the end of the pachytene stage in the mouse.
The fact that the drug inhibits both Hsp90 isoforms might also
contribute to these differences.
Discussion
Until now, the specific functions of Hsp90a have not been
investigated genetically at the organismic level in mammals. The
results of our work have shown an apparently exclusive
requirement for this particular isoform for spermatogenesis. It
appears that Hsp90a must be present at least during the first wave
of spermatogenesis, and its absence cannot be compensated by
Hsp90b and has long lasting consequences even if Hsp90a
expression resumes later. In the absence of Hsp90a, meiosis arrests
very specifically towards the end of the pachytene stage,
homologous chromosomes fail to disassemble and normal
diplotene spermatocytes are totally absent. Subsequently, there is
a progressive loss of germ cells in meiosis resulting in empty
seminiferous tubules and a reduced testicular size. Based on these
observations and on previous knowledge from the literature, we
would like to suggest that the molecular chaperone Hsp90a,
possibly through an interplay with Hsp70-2, is involved directly or
indirectly in the disassembly of the SC.
We were surprised to find that the only apparent phenotype
caused by the absence of Hsp90a is an azoospermia due to a very
specific meiotic arrest in pachytene. Even though Hsp90b is quite
ubiquitously present throughout the body, one might have
expected additional defects based on the emerging notion that
there may be isoform-specific functions. Investigating some of
these, such as the role of Hsp90a in antigen presentation and in
cancer metastasis, would require specific tests and challenges that
we have yet to set up. Considering the relatively high levels of
expression of Hsp90a in brain and testis, it is gratifying that at least
one of these organs showed an obvious phenotype.
Both Hsp90 isoforms are present in the mammalian testis.
Contrary to Hsp90b, which is mainly expressed in Sertoli cells in
the mouse, Hsp90a expression is more specific to primordial and
mature germ cells [42,43], although some expression in Sertoli
cells is also seen [27]. In this complex organ, Hsp90b, despite
being expressed, is clearly not able to complement for the loss of
Hsp90a. Its levels, which apparently are not compensated in
hsp90a mutant mice, might be too limiting in germ cells. Another
surprising observation is the absence of a comparable phenotype
in hsp90a mutant females (data not shown). In view of the fact that
the knowledge about the regulation of the cell cycle and apoptosis
in mammalian meiosis is still rather limited [44–46], this remains
difficult to interpret. A previous publication had speculated that
the defect in female meiosis of an Hsf1 mouse knock-out could be
due to severely reduced Hsf1-controlled levels of Hsp90a [10].
While this may have contributed, the absence of Hsf1 is likely to
have perturbed the expression of a whole panel of factors and the
Hsp90 inhibitor, which was shown to mimic some of the defects of
the mutation in an in vitro assay for oocyte maturation, would have
inhibited Hsp90a and Hsp90b alike. The role of Hsp90 in
oogenesis is nevertheless worth further investigations as a mutation
in the single gene encoding the cytosolic Hsp90 gene in the
nematode Caenorhabditis elegans was reported to result in an arrest at
Figure 7. The Hsp90 inhibitor pochoxime affects testis growth.
(A) Reduction of testis weight upon intraperitoneal administration of
pochoxime A or vehicle. n=6 for treated, n=5 for control animals;
p=0.01. (B) Exterior morphology of mouse testes at P25 after
administration of pochoxime A or vehicle. Testis size is reduced, in
some cases atrophic (asterix). C, vehicle; P, pochoxime A.
doi:10.1371/journal.pone.0015770.g007
Hsp90a Required for Spermatogenesis
PLoS ONE | www.plosone.org 7 December 2010 | Volume 5 | Issue 12 | e15770the prophase/metaphase boundary [47]. Unfortunately, the
impact on spermatogenesis in this organism was not evaluated.
We used a candidate gene/protein approach to try to uncover
the molecular mechanisms underlying the phenotype of the hsp90a
mutation. On the one hand, we compared our phenotype to that
of mutations in other genes that yield a spermatogenesis defect in
the mouse and that encode Hsp90 clients and more generally any
Hsp90- or Hsp70-related proteins. On the other hand, we
determined whether the levels of certain candidate proteins were
affected by the mutation since degradation is a common hallmark
of Hsp90 clients upon Hsp90 inhibition. Considering the global
role of Hsp90 and the complexity of its interactome, speculating
about possible relevant targets is not trivial. A confounding
difficulty stems from the fact that the relative contributions of
different cell populations in the testis are altered in mutant
animals. Nevertheless, this analysis suggests that multiple but
perhaps interlinked pathways may be affected resulting specifically
in a pachytene arrest and overall disruption of spermatogenesis.
No reported deletion of a gene encoding an Hsp90 client or
cochaperone with a spermatogenesis defect in the mouse gives
exactly the same phenotype [45,48]. That of the hsp70-2 knock-out
perhaps most closely resembles the phenotype of the hsp90a
mutation. In this case, spermatogenesis also proceeds until the final
pachytene substage, the chromosomes align but fail to disassemble
and normal diplotenespermatocytes areabsent[49]. SinceHsp70-2
binds SCsandhasbeen proposedto beinvolvedinorchestrating the
crucial cell cycle transition that is relevant to our phenotype [35],
several additional players were worth considering. In keeping with
the hypothesis, Cdc2 levels remain unchanged in hsp70-2 mu-
tant testes but Cdc2 kinase activity fails to be acquired [30].
Unfortunately, the mouse deletion mutants of the genes for NASP,
cyclin B1, and Cdc2 (= Cdk1) are not informative since they are
embryonically lethal [50–52]. The knock-out of the gene for the
testis-specific cyclin isoform A1 in turn does display a spermato-
genesis defect, but meiosis is arrested at diplotene [53], that is later
than in our hsp90a mutant. In the case of the cdk2knock-out,there is
a spermatogenesis defect associated with a pachytene arrest, but it is
associated with aberrant chromosome pairing [54], which we have
not observed. Surprisingly, the knock-out of the mouse gene for the
testis-specific histone H1t does not affect spermatogenesis [33].
Coincident with the observation that the lack of at least some of
these Hsp90/Hsp70-2-related proteins leads to a spermatogenesis
defect in the mouse, we see changes in the abundance of some of
these proteins. Specifically, the levels of NASP, Hsp70-2 and
Cdc2, both total and in its dephosphorylated active form, are
reduced. For the Hsp90 client Cdc2, this could be expected, in
particular because the mere reduction of Hsp90a expression had
been demonstrated to cause an instability of Cdc2 and a block of
cell cycle progression in tissue culture cells [55]. For NASP and
Hsp70-2, which could rather be classified as Hsp90 coregulators or
partners, this would be rather unexpected. Whether there is
indeed an interaction between Hsp90a and Hsp70-2, as suggested
by the earlier observation of a Hsp90-Hsp70 complex in testis
extracts [27], and whether Hsp70-2 is destabilized in the absence
of Hsp90a, remains to be seen. As pointed out before, we cannot
easily standardize these protein levels to the remaining amounts of
spermatocytes relative to the other cell types in testis. However, we
find these changes as early as P21, when the depletion of germ line
cells is still in its early stages. We therefore speculate that the
reduced levels of some or all of these regulatory proteins impair the
formation of the H1t/NASP/Hsp-70/Cdc2 complex and the
transition to the activation of the Cdc2/cyclin B complex (MPF)
for progression beyond pachytene. An alternative, albeit not
mutually exclusive, hypothesis builds on the similarity of the hsp70-
2 and hsp90a mutant phenotypes and on the observation that
Hsp70-2 localizes to SCs [49]. Unless the effects on the levels of
the afore-mentioned proteins are coincidental, it is tempting to
speculate that the molecular chaperones Hsp70-2 and Hsp90a
may be involved in the disassembly of SCs.
Our finding that an Hsp90 inhibitor can phenocopy the hsp90a
mutation, at least when applied during puberty, may have
implications for the future clinical use of such drugs. Several
Hsp90 inhibitors are currently in clinical trials as anti-cancer drugs
[37] and may eventually also be explored for even more long-term
treatments, for example against neurodegenerative diseases. It is
presently not known whether such a therapy would have an impact
on male fertility. In this context, it is noteworthy that we achieved
the pharmacological modulation of male fertility in mice at ten-fold
lower doses than those commonly applied for tumor inhibition
[39]. Considering the impact of a genetic disruption of the Hsp90a
gene or of the pharmacological treatment with a drug that is not
Hsp90 isoform-specific, the potential side effects of the current
generation of drugs and, perhaps some time in the future, of
isoform-selective ones need to be more carefully evaluated. Unlike
the effects of an application during puberty, as in our experiments
with mice, specific Hsp90 inhibitors given to human adults may
well prove to be innocuous for fertility. And yet, caution is
warranted as further emphasized by the finding that gamendazole,
which has been advocated as a potential oral and nonhormonal
single dose male contraceptive, apart from other protein(s) also
binds Hsp90 albeit with a distinct pharmacological profile than
inhibitors targeting the N-terminal nucleotide binding pocket [56].
Materials and Methods
Ethics statement
Animal husbandry and all animal experimentation was carried
out in compliance with Swiss laws. Approval was obtained from
the University of Geneva ‘‘animal experimentation ethics
committee’’ (protocol number 10–11) and formal authorisations
(numbers 31.1.1027/3263/1 and 31.1.1027/3576/2) were ob-
tained from the State and Federal authorities.
Generation of mutant mouse lines and genotyping
The 129P2 ES cell clone XE444 with the gene trap vector
pGT1Lxf in the Hsp90aa1 gene was obtained from Baygenomics,
now part of the International Gene Trap Consortium (http://
www.genetrap.org). The mouse line Hsp90aa1
Gt(XE444)Byg was
established by injection of XE444 cells into C57BL/6 blastocysts
and is herein referred to as mutant mouse line 1 or hsp90a
gt/gt.
After germ line transmission was obtained, mice were main-
tained by breeding with C57BL/6. The second mouse line,
Hsp90aa1
Gt(S17-2G1)Sor (herein referred to as mutant mouse line 2)
was generated from the 129S4/SvJae ES cell clone S17-2G1
containingthe gene trapvector ROSAFARYin the Hsp90aa1gene.
Chimeras for this line were obtained from the Mutant Mouse
Regional Resource Centers at the University of California, Davis
(http://www.mmrrc.org). Genotyping by PCR was done with
DNA isolated from tail or ear biopsies using the Direct PCR Lysis
Reagent (Viagen Biotech). PCR primers were directed to the
integrated gene trap sequence and the flanking parts of the
Hsp90aa1 intron 10 and exon 11 for line 1, and sequences around
the insertion site of the ROSAFARY gene trap vector in intron 1 of
the Hsp90aa1 gene for line 2. Primer details are given in Table S1.
Immunoblotting
Protein extracts were prepared by homogenisation of mouse
organs in protein isolation buffer (10 mM Tris-HCl pH 8, 1%
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phosphatase and proteinase inhibitor cocktails) with an Amaxa
tissue homogenizer, sonicated, and resolved by SDS-polyacryl-
amide gel electrophoresis. For immunoblotting, the following
antibodies were used: the Hsp90a-specific polyclonal antibody
PA3-013 (Affinity BioReagents), the monoclonal Hsp90b-specific
antibody H90-10 (a kind gift of Dr. David Toft), the rabbit
polyclonal antisera 9112 and 9111 against Cdc2 and phospho-
Cdc2 (Cell Signalling), respectively, the NASP-specific polyclonal
antibody 72494 (Abcam), the monoclonal antibody HPA000798
against Hsp70-2 (Atlas Antibodies AB), the monoclonal antibody
GNS11 against cyclin B (Neomarkers), and the monoclonal anti-
GAPDH antibody 6C5 (Abcam). In some cases, immunoblots
were quantitated by acquiring the chemiluminescent signal with a
Syngene GeneGnome.
Histological examination and immunohistochemistry
Freshly dissected testes were fixed in Bouin’s solution for
hematoxylin and eosin staining and in 4% paraformaldehyde for
immunostaining, washed in phosphate-buffered saline (PBS) and
embedded in paraffin. Eight 5 mm sections per adult testis, taken at
different levels, were selected for investigating the size of the
seminiferous tubules and to assess the different stages of
spermatogenesis. For immunohistochemistry, the sections were
stained with a 50-fold dilution of the polyclonal GATA4 antibody
sc-9053 (Santa Cruz Biotechnology) after standard antigen
retrieval. Images were taken with a Zeiss AxioCam microscope.
Sperm counts
To determine the epididymal sperm counts, the caudal
epididymides and deferent ducts were surgically removed from
adult mice, washed with PBS, cut into pieces with scissors, and
carefully squeezed with forceps in order to release the sperm
content into 250 ml of pre-warmed M2 medium. After eosin-
negrosin staining, the total epididymal sperm counts were assessed
using a Neubauer hemocytometer.
Flow cytometry
Flow cytometric analyses were done essentially as previously
described [57]. Briefly, testes from P44 wild-type and hsp90a
gt/gt
mice (n=3 per group) were dissected and decapsulated to release
the tubules, which were then incubated in 0.25 mg/ml collagenase
type IV (Sigma) at 37uC for up to 5 min with rapid agitation.
Dispersed tubules were allowed to settle and washed twice to
remove peritubular cells. Washed tubules were then incubated
with 0.5% Trypsin EDTA (Gibco) and 1 mg/ml DNase RQ1
(Promega) at 37uC for 5 min with agitation. Trypsin digestion was
terminated by adding DMEM with 10% FCS. The suspension was
washed and disaggregated into a single-cell suspension by
trituration using a flame-polished Pasteur pipette and filtered
through a 50 mm cell strainer. For DNA content and nuclear
analysis, germ cells were rinsed and resuspended in 1 ml of cold
propidium iodide (PI) staining solution (10 mM Tris-HCl pH 8.0,
1 mM NaCl, 0.1% Nonidet-P40, 50 mg/ml PI, 10 mg/ml RNa-
seA), vortexed for 2–3 sec and incubated on ice for 10 min to lyse
the plasma membrane and stain nuclear DNA. DNA content was
assessed on a FacsCalibur II (Becton-Dickinson) equipped with the
CELL Quest software.
Real-time quantitative RT-PCR
This was performed essentially as previously described [58].
Total RNA from the testes of P44 mice (5 wild-type and 7
mutants) was extracted with the Trizol reagent. Subsequently,
RNA preparations were treated with DNAse I and re-purified with
the RNeasy minicolumn elution kit from QIAGEN according to
the manufacturer’s instructions. RNA integrity and quantity were
assessed with an Agilent 2100 bioanalyzer, using RNA 6000
nanochips. Total RNA samples were reverse transcribed with the
Superscript III reverse transcriptase (Invitrogen) according to the
manufacturer’s protocol. One-twentieth cDNA template was used
as template for each PCR reaction. cDNA was PCR amplified in a
7900HT Sequence Detection Systems (Applied Biosystems) using
the Power SYBR Green PCR master mix (Applied Biosystems).
Raw threshold-cycle (Ct) values were obtained with the Sequence
Detection Systems 2.0 software (Applied Biosystems). Relative
quantities (RQs) were calculated with the formula RQ=E2Ct,
using efficiencies calculated for each run with the Data Analysis for
Real-Time PCR (DART-PCR) algorithm, as described [59]. A
mean quantity was calculated from triplicate PCR reactions for
each sample, and this quantity was normalized to two similarly
measured values of normalization genes (glyceraldehyde-3-phos-
phate dehydrogenase and b-actin). Normalized quantities were
averaged for seven wild-type and five mutant animal samples. The
normalized relative quantity of the wild-type was arbitrarily given
a value of 100% and the % change was calculated for the mutant
animals. They were expressed +/2standard error. Details on
primers are given in Table S1.
Meiotic chromosome spreads
Spreads were prepared by the dry-down technique as previously
described [60]. Briefly, testes were dissected, the albuginea layer
removed, tubules cut into small pieces and dissociated with a pipet
in PBS. Cells were ruptured by adding equal amounts of hypotonic
buffer (30 mM Tris-HCl pH 8.2, 50 mM sucrose, 17 mM sodium
citrate, 5 mM EDTA, 0.5 mM DTT, protease inhibitors) and
mixed 1:2 with 100 mM sucrose just before spreading on the
slides. The slides were dipped in the paraformaldehyde solution,
incubated in a humid chamber for 1 h and then dried for 30 min.
Slides were washed 261 min with 0.08% Photo-flo (Kodak).
Immunostaining of spermatocyte spreads was carried out as
described [61], using a milk-based blocking buffer (5% milk, 5%
donkey serum in 1xPBS). Antibodies used were: monoclonal
antibodies against Sycp1 (a gift from C. Heyting), phospho-H2A.X
(Upstate) and MLH1 (Pharmingen), a guinea pig antiserum
against Sycp3 and a rabbit antiserum against DMC1 (Santa Cruz
Biotechnology) at 500-, 25’000-, 50-, 500-, and 200-fold dilutions,
respectively. All incubations with primary antibodies were carried
out overnight at room temperature. Secondary antibodies were
goat anti-guinea pig Alexa Fluor 488 (Molecular probes), donkey
Cy5-conjugated antimouse and Cy3-conjugated anti-rabbit anti-
bodies. Incubations with secondary antibodies were carried out at
37uC for 90 min. Nuclei were stained with DAPI (2 mg/ml)
during the final washing step. Digital images were obtained by
using a cooled CCD camera, Coolsnap HQ (Photometrics),
coupled to a Leica DMRA2 microscope using the same exposure
time for all aquisitions. Each colour signal was acquired as a black-
and-white image using appropriate filter sets and was merged with
Photoshop Imaging software using the same entry levels for each
histone modification in order to be able to compare the staining
intensity at different stages of meiosis.
Pochoxime inhibitor study
Wild-type B6CBA F1 males were injected intraperitoneally
every day from P12 to P25 with 10 mg of pochoxime A per kg of
body weight. The inhibitor was dissolved in DMSO to 100 mg/ml
and stored at 220uC. A working dilution of 1 mg/ml was prepared
by diluting the pochoxime A stock solution first with Tween-20
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1:0.5:8.5. Wild-type controls were injected with the same solvent
without pochoxime A. Animals were sacrificed for analysis on P25.
Supporting Information
Figure S1 Functional hsp90a gene disruption mouse line 2. (A)
Schematic representation of the disruption of the mouse Hsp90aa1
gene by insertion of a gene trap (GT) into the first intron. Open
and black boxes indicate non-coding and coding exons, respec-
tively. The gene trap consists of a splice acceptor (SA), a b-
galactosidase-neomycin resistance fusion (bGeo) and an SV40
polyadenylation site. (B) and (C) Immunoblots showing the
expression of Hsp90a and Hsp90b in wild-type (+/+) and mutant
(2/2) mice; in testes over time after birth for panel B and in
different tissues at 8 months in panel C. (D) Time course analysis
of testis weight in WT and mutant (gt/gt) animals. (E) Histological
sections of testes of of wild-type (WT) and mutant (gt/gt) mice at
P70. Two different magnifications are shown.
(TIF)
Figure S2 Sertoli cell function appears normal. (A) Immunohis-
tochemical staining for the Sertoli marker GATA4 in 4 months old
testes of wild-type and hsp90a
gt/gt mutant animals. Asterix indicates
a SCO tubule. Blue, DAPI staining; green, GATA4 staining. (B)
Quantitative RT-PCR analysis of other Sertoli cell-specific
markers at P44.
(TIF)
Figure S3 DSB repair processes and homologous recombination
proceed normally in hsp90a
gt/gt spermatocytes. Staining for
cH2AX (green) reveals the formation of DSBs, first detected at
leptotene, DMC1 (green) at sites of DSB repair and MLH1 (green)
at sites of crossing over. Chromosome axes are stained with Sycp3
(red) and DNA with DAPI (blue). Samples are from animals at
P28.
(TIF)
Table S1 Oligonucleotides used for genotyping and quantitative
RT-PCR.
(DOC)
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